Biochemical markers of bone turnover and clinical outcome in patients with renal cell and bladder carcinoma with bone metastases following treatment with zoledronic acid: The TUGAMO study. [electronic resource]
Producer: 20130920Description: 121-30 p. digitalISSN:- 1532-1827
- Adult
- Aged
- Aged, 80 and over
- Alkaline Phosphatase -- blood
- Biomarkers, Tumor -- blood
- Bone Density Conservation Agents -- therapeutic use
- Bone Neoplasms -- drug therapy
- Bone Remodeling
- Bone and Bones -- enzymology
- Carcinoma, Renal Cell -- metabolism
- Collagen Type I -- blood
- Diphosphonates -- therapeutic use
- Disease Progression
- Female
- Humans
- Imidazoles -- therapeutic use
- Kidney Neoplasms -- metabolism
- Male
- Middle Aged
- Peptide Fragments -- blood
- Procollagen -- blood
- Prospective Studies
- Treatment Outcome
- Urinary Bladder -- metabolism
- Urinary Bladder Neoplasms -- metabolism
- Zoledronic Acid
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.